查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726343

美國腫瘤資訊系統市場規模、佔有率、趨勢分析報告（按產品/服務、應用、最終用途、細分市場預測，2025 年至 2030 年）

U.S. Oncology Information Systems Market Size, Share & Trends Analysis Report By Products & Services, By Application, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年美國腫瘤資訊系統 (OIS) 市場規模將達到 9.029 億美元，2025 年至 2030 年的複合年成長率為 7.40%。

各個人群中癌症盛行率的上升以及對先進創新腫瘤資訊系統 (OIS) 的需求不斷增加是美國腫瘤資訊系統產業發展的促進因素。癌症盛行率的上升和醫療保健預算的增加正在推動美國各地的醫院和癌症研究機構採用癌症資訊解決方案。

由於癌症發病率的上升和先進醫療 IT 解決方案的日益融合，美國的 OIS 行業預計將經歷顯著成長。根據美國癌症實驗室的數據，到 2024 年，美國將新增超過 200 萬例癌症病例，並有 611,720 例癌症相關死亡病例。疾病盛行率的增加需要強大的數據管理和臨床決策支援系統，從而加速了醫療機構對 OIS 平台的需求。

此外，美國醫療保健產業正在迅速採用數位技術，旨在最佳化工作流程、管理職能和患者照護服務。具有治療計劃、數據視覺化和患者追蹤等先進功能的腫瘤資訊系統已成為改善臨床結果和業務效率的關鍵工具。

此外，公共和私人實體支持對腫瘤學研究和開發的投資不斷增加，正在刺激產品創新。例如，美國近距離放射治療協會（ABS）是一家成立於 1978 年的著名非營利組織，它透過專業教育、研究促進和提高意識的舉措積極支持近距離放射治療的發展。這些組織在推動癌症治療的創新和知識傳播方面發揮著至關重要的作用。

此外，人工智慧 (AI) 擴大融入腫瘤學工作流程預計將進一步推動市場擴張。 2024 年 10 月，McKesson Corporation 的子公司 Ontada 與微軟合作，利用 Azure AI（包括 Azure OpenAI 服務）增強對非結構化腫瘤資料的處理。此次合作旨在從複雜的臨床文獻中獲得可行的見解，最終支持數據主導的治療計劃和即時決策。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國腫瘤資訊系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國腫瘤資訊系統市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國腫瘤資訊系統市場（按產品/服務、估計和趨勢分析）

  • 細分儀表板
  • 美國腫瘤資訊系統市場產品與服務變化分析
  • 美國腫瘤資訊系統市場規模和趨勢分析（按產品和服務，2018-2030 年）
  • 軟體
    • 病人資訊系統
    • 治療計劃系統
  • 專業服務

第5章美國腫瘤資訊系統市場的應用、估計與趨勢分析

  • 細分儀表板
  • 美國腫瘤資訊系統市場使用趨勢分析
  • 美國腫瘤資訊系統市場規模及應用趨勢分析（2018-2030）
  • 腫瘤內科
  • 放射腫瘤學
  • 外科腫瘤學

第6章美國腫瘤資訊系統市場最終用途、估價與趨勢分析

  • 細分儀表板
  • 美國腫瘤資訊系統市場最終用途趨勢分析
  • 2018 年至 2030 年美國腫瘤資訊系統市場規模及趨勢分析（依最終用途）
  • 醫院和診斷影像
  • 消融治療中心和癌症治療中心
  • 政府
  • 研究設施

第7章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Elekta AB
    • Accuray Incorporated
    • Varian Medical Systems（Siemens Healthineers）
    • RaySearch Laboratories
    • Cerner Corporation（Oracle Corporation）
    • BrainLab
    • Philips Healthcare
    • Prowess, Inc.
    • DOSIsoft SA
    • ViewRay Inc.
    • MIM Software
    • Flatiron
Product Code: GVR-4-68040-287-5

Market Size & Trends:

The U.S. oncology information systems market size was estimated at USD 900.29 million in 2024 and is projected to grow at a CAGR of 7.40% from 2025 to 2030. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems (OIS) are some of the driving factors for the U.S. oncology information systems industry. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.

The U.S. OIS industry is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.

Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.

Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.

In addition, the growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel market expansion. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.

U.S. Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. oncology information systems market report based on products & services, application, and end use:

  • Products & Services Outlook (Revenue, USD Million, 2018 - 2030)
  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Professional Services
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Products & Services Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. U.S. Oncology Information Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Oncology Information Systems Market: Products & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Oncology Information Systems Market Products & Services Movement Analysis
  • 4.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Patient Information Systems
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Treatment Planning Systems
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Professional Services
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Oncology Information Systems Market Application Movement Analysis
  • 5.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Medical Oncology
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Radiation Oncology
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Surgical Oncology
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Oncology Information Systems Market End Use Movement Analysis
  • 6.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals & Diagnostic Imaging
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Ablation Care Centers and Cancer Care Centers
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Government Institutions
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Research Facilities
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Elekta AB
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Accuray Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Varian Medical Systems (Siemens Healthineers)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. RaySearch Laboratories
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Cerner Corporation (Oracle Corporation)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. BrainLab
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Philips Healthcare
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Prowess, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. DOSIsoft S.A.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. ViewRay Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. MIM Software
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Flatiron
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. oncology information systems market, by component, 2018 - 2030 (USD Million)
  • Table 3 U.S. oncology information systems market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. oncology information systems market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. oncology information systems market: Market outlook
  • Fig. 5 U.S. oncology information systems market: Segment outlook
  • Fig. 6 U.S. oncology information systems market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. oncology information systems market driver impact
  • Fig. 9 U.S. oncology information systems market restraint impact
  • Fig. 10 U.S. oncology information systems market: Products & Services outlook and key takeaways
  • Fig. 11 U.S. oncology information systems market: Products & Services movement analysis
  • Fig. 12 Software market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Patient information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Treatment planning systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Professional services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. oncology information systems market: Application outlook and key takeaways
  • Fig. 17 U.S. oncology information systems market: Application movement analysis
  • Fig. 18 Medical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Medical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Surgical oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. oncology information systems market: end use outlook and key takeaways
  • Fig. 22 U.S. oncology information systems market: end use movement analysis
  • Fig. 23 Hospitals & diagnostic imaging centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Ablation care centers and cancer care centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Government institutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Research facilities market estimates and forecasts, 2018 - 2030 (USD Million)